DNTH — Dianthus Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.17bn
- $3.28bn
- $2.04m
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise
Dianthus Therapeutics Inc expected to post a loss of 86 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-IBM, Lumentum Holdings, TransDigm Group
Dianthus Therapeutics Q1 net loss widens on higher expenses
U.S. STOCKS ON THE MOVE-Agricultural stocks, Papa John's, Oil companies
U.S. STOCKS ON THE MOVE-Nebius, Scienture, Clearmind
Dianthus Therapeutics slips premarket after increased $625 mln share sale
Brief: Dianthus Therapeutics Says Co. Prices Upsized Offering Of 7,313,582 Shares At $81.00 Per Share
Brief: Dianthus Therapeutics Announces Proposed $400 Million Underwritten Public Offering
Dianthus Therapeutics slips after starting $400 mln stock sale
U.S. STOCKS ON THE MOVE-Hewlett Packard Enterprise, Dianthus, 3D Systems
Dianthus jumps after nerve disease drug shows faster‑than‑expected response in trial
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Dianthus Therapeutics May Issue Up To $600 Million In Securities
Brief: Leads Biolabs And Dianthus Therapeutics Announce Initiation Of Phase 1 Trial Of LBL-047 (Dnth212) In Healthy Volunteers And Patients With Systemic Lupus Erythematosus
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy